Ms Scallon, MEP:

It is clear that the biotechnology industry is driving this. The BBC coverage of the vote in the Parliament last week suggested that this was for the biotech companies in Europe to catch up with those in Asia and China and to be one step ahead of the US biotech companies, whether one should have the drugs—